| Autor: |
Ferrer, Cristina Suárez, Gismero, Francisco Mesonero, Caballol, Berta, Ballester, Maria Pilar, Rey, Iria Bastón, García, Andrés Castaño, Bautista, Jose Miranda, Chumillas, Rosa Saiz, Benitez, Jose Manuel, Delgado, Laura Sanchez, García, Alicia López, de Celix, Cristina Rubin, Abreu, Inmaculada Alonso, Melcarne, Luigi, Santos, Rocío Plaza, Camí, Miquel Marques, Mateos, Antonio Caballero, Díez, César Gómez, Calafat, Margalida, Galan, Horacio Alonso, Vilaamil, Pablo Vega, Senosiain, Beatriz Castro, Moya, Andrea Guerro, Rodriguez Diaz, Carmen Yolanda, Spicakova, Katerina, Marcos, Noemi Manceñdo, Molina, Gema, Castro Parga, Luisa de, Angulo, Andres Rodriguez, del Campo, Lidia Cuevas, Rodriguez Grau, Maria del Carmen, Ramirez, Fernando, Pastrana, Barbara Gomez, Partida, Irene Gonzalez, Mateu, Belen Botella, Gonzalez, Elena Peña, Iyo, Eduardo, Gonzalez, Alfonso Elosua, Arnau, Empar Sainz, Villalba, Luis Hernandez, Galindo, Pablo Perez, Medina, Leyanira Torrealba, Alonso, Sara Monsalve, Olmos Perez, Jose Antonio, Sadornil, Carmen Dueñas, Ramirez, Laura Garcia, Martín-Arranz, María Dolores, Sanroman, Antonio López, Fernández, Agnès, Murgui, Victor Merino, Suárez, Cristina Calviño, Florez, Pablo, Lobato matilla, María Elena, Sicilia, Beatriz, Escribano, Pilar Soto, Martin, Carlos Maroto, Mañosa, Míriam, De Acosta, Manuel Barreiro |
| Zdroj: |
Gastroenterología y Hepatología (ScienceDirect); 20240101, Issue: Preprints |
| Abstrakt: |
INTRODUCTION: Biological therapies used for the treatment of inflammatory bowel disease (IBD) have shown to be effective and safe, although these results were obtained from studies involving mostly a young population, who are generally included in clinical trials. The aim of our study was to determine the efficacy and safety of the different biological treatments in the elderly population. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
